Overall, our results support the notion that Hsp40 initially acts in a cytoprotective capacity to suppress toxic TDP-43 aggregation, but may be insufficient to counteract the full burden of TDP-43 pathology that accumulates in end-stage ALS spinal cord. Here, DNAJB1 is linked to amyotrophic lateral sclerosis.